Dr. Manuel Berzosa Corella, MD

Dr. Berzosa Corella practices at Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida.

Dr. Berzosa Corella's NPI, 1336317171, was assigned on February 14, 2008. Dr. Berzosa Corella graduated from Universidad de Ciencias Medicas in 2004. Dr. Berzosa Corella holds Florida license ME116511.

Dr. Berzosa Corella's primary practice is Mount Sinai Medical Center, at 4300 Alton Rd, Miami Beach, FL 33140 in Miami-Dade County. The practice phone is (305) 674-2121.

Dr. Berzosa Corella's primary practice is Mount Sinai Medical Center in Miami Beach, Florida, part of Mount Sinai Medical Center of Florida. The medical group on file is Mount Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Berzosa Corella practices. Vendor and product names are available with a free account.

Gastroenterology is Dr. Berzosa Corella's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Berzosa Corella is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Berzosa Corella's licenses on file in 3 states: Florida, Texas and Minnesota.

Dmand AI lists acid reflux, acute gastroduodenitis, cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis, gastroenteritis and gastrointestinal bleeding among the conditions Dr. Berzosa Corella treats.

CMS data shows 740 Medicare services from Dr. Berzosa Corella across 19 procedure codes in 2024, for 383 Medicare patients. Medicare paid $86,014 for them.

CMS counts 383 Medicare patients who saw Dr. Berzosa Corella in 2024. The largest group is 65 to 74, with 167 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Berzosa Corella's median patient age at 67, with 55% women.

In 2024, Dr. Berzosa Corella wrote 582 Medicare Part D claims for 243 patients. 76% of them were for generic drugs. CMS names the drug for 452 of them, across 13 drugs with 11 or more claims each, at $313,783 in total drug cost. In 2023, CMS named 638 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Berzosa Corella for performance year 2024, reported through an alternative payment model (APM). Dr. Berzosa Corella accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Berzosa Corella as offering telehealth. CMS counts 289 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Berzosa Corella, more than 95% of the clinicians it reports for that procedure.

CMS Open Payments shows 742 general payments to Dr. Berzosa Corella from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $2,905.

Dr. Berzosa Corella graduated from Universidad de Ciencias Medicas in 2004.

Dr. Berzosa Corella is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.